what's better mounjaro or semaglutide Ozempic vs the difference? Both medications support weight management and blood sugar control, but they work differently in the body. Let's learn the key similarities and differences. 📲 Book a Tips to maintain weight loss

Description

(NYSE: PFE) announced positive topline results from the phase 2b VESPER-3 study investigating monthly maintenance dosing of its fully-biased, ultra-long-acting, injectable GLP-1 receptor agonist (RA) PF3944 (MET-097i) in adults with obesity or overweight without type 2 diabetes

As a trusted metabolism booster, Saba GLP-1 may help support balanced eating habits and long-term metabolic wellness when combined with proper nutrition and exercise

To maximize safety and feasibility, only the 2 lowest dose sequences (0.25 mg/week for weeks 1-4 and 0.5 mg/week for weeks 5-8) were used prior to primary outcome collection (between weeks 8 and 9)